71 related articles for article (PubMed ID: 8572761)
1. Should cavitated bronchopulmonary cancers be considered a separate entity?
Mouroux J; Padovani B; Elkaïm D; Richelme H
Ann Thorac Surg; 1996 Feb; 61(2):530-2. PubMed ID: 8572761
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluoro-2-deoxy-D-glucose standardized uptake value in cavitating non-small-cell lung carcinoma.
Coffey JP; Hill JC
Nucl Med Commun; 2008 Dec; 29(12):1040-5. PubMed ID: 18987523
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
Yi SZ; Zhang DC; Wang YG; Sun KL
Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography. An effective technique for mediastinal staging in lung cancer.
Daly BD; Faling LJ; Pugatch RD; Jung-Legg Y; Gale ME; Bite G; Snider GL
J Thorac Cardiovasc Surg; 1984 Oct; 88(4):486-94. PubMed ID: 6482485
[TBL] [Abstract][Full Text] [Related]
6. Cavitated tumor as a clinical subentity in squamous cell lung cancer patients.
Kolodziejski LS; Dyczek S; Duda K; Góralczyk J; Wysocki WM; Lobaziewicz W
Neoplasma; 2003; 50(1):66-73. PubMed ID: 12687281
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of screen-detected lung cancers.
Kawachi R; Watanabe S; Asamura H
J Thorac Oncol; 2009 May; 4(5):615-9. PubMed ID: 19318993
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer.
Gasinska A; Kolodziejski L; Niemiec J; Dyczek S
Lung Cancer; 2005 Aug; 49(2):171-9. PubMed ID: 16022910
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
10. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest.
Daly BD; Mueller JD; Faling LJ; Diehl JT; Bankoff MS; Karp DD; Rand WM
J Thorac Cardiovasc Surg; 1993 May; 105(5):904-10; discussion 910-1. PubMed ID: 8487569
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
13. [Cavernous bronchus carcinoma].
Schamaun M; Rüttimann A
Schweiz Med Wochenschr; 1986 Sep; 116(37):1249-52. PubMed ID: 3764396
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle metastasis from non-small cell lung cancer.
Pop D; Nadeemy AS; Venissac N; Guiraudet P; Otto J; Poudenx M; Mouroux J
J Thorac Oncol; 2009 Oct; 4(10):1236-41. PubMed ID: 19641472
[TBL] [Abstract][Full Text] [Related]
15. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
[TBL] [Abstract][Full Text] [Related]
16. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
18. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
[TBL] [Abstract][Full Text] [Related]
19. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
20. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
